- Home
- FFWM vs ABUS Comparison
FFWM vs ABUS Comparison
Compare FFWM & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFWM
- ABUS
- Stock Information
- Founded
- FFWM 1990
- ABUS N/A
- Country
- FFWM United States
- ABUS United States
- Employees
- FFWM N/A
- ABUS N/A
- Industry
- FFWM Major Banks
- ABUS Biotechnology: Pharmaceutical Preparations
- Sector
- FFWM Finance
- ABUS Health Care
- Exchange
- FFWM Nasdaq
- ABUS Nasdaq
- Market Cap
- FFWM 630.9M
- ABUS 697.3M
- IPO Year
- FFWM 2014
- ABUS N/A
- Fundamental
- Price
- FFWM $6.99
- ABUS $3.34
- Analyst Decision
- FFWM Buy
- ABUS Strong Buy
- Analyst Count
- FFWM 5
- ABUS 4
- Target Price
- FFWM $7.80
- ABUS $5.50
- AVG Volume (30 Days)
- FFWM 353.4K
- ABUS 774.4K
- Earning Date
- FFWM 01-23-2025
- ABUS 11-06-2024
- Dividend Yield
- FFWM 0.29%
- ABUS N/A
- EPS Growth
- FFWM N/A
- ABUS N/A
- EPS
- FFWM N/A
- ABUS N/A
- Revenue
- FFWM $108,182,000.00
- ABUS $6,742,000.00
- Revenue This Year
- FFWM N/A
- ABUS N/A
- Revenue Next Year
- FFWM $31.32
- ABUS N/A
- P/E Ratio
- FFWM N/A
- ABUS N/A
- Revenue Growth
- FFWM N/A
- ABUS N/A
- 52 Week Low
- FFWM $4.84
- ABUS $2.19
- 52 Week High
- FFWM $11.47
- ABUS $4.72
- Technical
- Relative Strength Index (RSI)
- FFWM 37.61
- ABUS 40.38
- Support Level
- FFWM $6.94
- ABUS $3.59
- Resistance Level
- FFWM $7.42
- ABUS $3.61
- Average True Range (ATR)
- FFWM 0.29
- ABUS 0.14
- MACD
- FFWM -0.12
- ABUS -0.00
- Stochastic Oscillator
- FFWM 7.66
- ABUS 15.12
About FFWM First Foundation Inc.
First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.